Selected conference papers will be recommended to be published in the “Journal of Personalized Medicine - Open access journal by MDPI”. All submissions should be extended (~60%) discount till March 2020 and manuscripts which are submitted after march will get the benefit of (50%) and will be subject to customary peer review of MDPI before they are considered for publication. As an Editorial Board Member of MDPI and a Scientific Committee of the conference, Prof. Dr. Sergey Suchkov will be responsible for the recommendation of conference papers after discussion with the conference committee and the journal editorial board members.
For more information about publishing procedure- https://www.mdpi.com/journal/jpm/special_issues/IPMC_2020
About the Journal:
Journal of Personalized Medicine (JPM; ISSN 2075-4426) is an international, open access journal aimed at bringing all aspects of personalized medicine to one platform. It focuses on “omics”-level studies that seek to define the basis of interindividual variation in susceptibility for a disease, its prognosis or definition of clinical subsets, and response to therapy (pharmacogenomics). We are also interested in systems biology as it relates to interindividual variation, and research on new methodologies, informatics, and biostatistics, in the aforementioned areas. JPM is indexed in ESCI-Emerging Sources Citation Index, PubMed and Scopus. Its CiteScore is 3.59 in 2018.
Note: Participants can submit their manuscripts to the “Journal of Personalized Medicine - Open access journal by MDPI” and avail 60% discount on article processing charges. Submitted papers will be peer reviewed once again and selected papers will be published as special issue.